SCHEMBL22928065

SCHEMBL22928065

CC(C)Sc1ccc(C(F)(F)F)cn1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 3/20 0.45
ALDH1A1 P00352 5/20 0.44
RECQL P46063 1/20 0.44
PKM P14618 1/20 0.43
KDM4E B2RXH2 3/20 0.40
DDB1 Q16531 1/20 0.40
CRBN Q96SW2 1/20 0.40
L3MBTL1 Q9Y468 2/20 0.40
KMT2A Q03164 1/20 0.40
NPSR1 Q6W5P4 1/20 0.39
NPC1 O15118 1/20 0.38
POLB P06746 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.36
TSHR P16473 1/20 0.36
HPGD P15428 1/20 0.36
PDE2A O00408 2/20 0.35
NOS1 P29475 1/20 0.35
APAF1 O14727 1/20 0.35
MAPT P10636 1/20 0.35
TDP1 Q9NUW8 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18780194 0.84 RAB9A (0.42) RAB9AALDH1A1RECQLPKMKDM4E
SCHEMBL6249003 0.79 KDM4E (0.49) RAB9AALDH1A1RECQLPKMKDM4E
SCHEMBL25325181 0.78 RAB9A (0.51) RAB9AALDH1A1RECQLPKMKDM4E
SCHEMBL28737917 0.75 RAB9A (0.49) RAB9AALDH1A1RECQLPKMKDM4E
SCHEMBL3323097 0.75 RAB9A (0.49) RAB9AALDH1A1RECQLPKMKDM4E
SCHEMBL24378525 0.75 ALDH1A1 (0.39) RAB9AALDH1A1RECQLPKMKDM4E
SCHEMBL14350432 0.74 ALDH1A1 (0.52) RAB9AALDH1A1RECQLPKMKDM4E
SCHEMBL24378510 0.74 ALDH1A1 (0.39) RAB9AALDH1A1RECQLPKMKDM4E
SCHEMBL1464378 0.73 POLB (0.55) RAB9AALDH1A1RECQLPKMKDM4E
SCHEMBL11476798 0.73 RAB9A (0.48) RAB9AALDH1A1RECQLPKMKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220127239-A1 GLYCOSYL DONOR, PREPARATION METHOD THEREFOR, AND USE THEREOF SICHUAN UNIVERSITY (CN) 2022-04-28 US disclosed
US-20210284805-A1 DESIGN OF LIGAND ATTACHMENT CHEMISTRY FOR HIGH CONDUCTIVITY POLYMER ELECTROLYTES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2021-09-16 US disclosed
WO-2021013155-A1 NOVEL GLYCOSYL DONOR, PREPARATION METHOD THEREFOR, AND USE THEREOF 四川大学 2021-01-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220127239-A1 GLYCOSYL DONOR, PREPARATION METHOD THEREFOR, AND USE THEREOF UGGT1, ALG8, FUT6 RAB9A 1546/4885ALDH1A1 689/4885RECQL 3098/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.